Price $1.04 |
Market Cap
53.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
3.89
|
P/S
266.19
|
Dividend %
-
|
|
P/CF
9.9
|
P/FCF
-
|
Op. Cash Flow
-13.4K
|
FCF
-0.2
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-76.20%
|
ROI
-51.30%
|
|
ROA
-57.00%
|
EPS Growth
-16.00%
|
Current Ratio
25.0
|
Debt/Equity
53.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| CYANOTECH CORP (CYAN) | $4.80 | - | - | 24.7M | Strong Buy |
| Rosetta Genomics Ltd. (USA) (ROSG) | $3.92 | - | - | 45.1M | Strong Buy |
| ImmuCell Corporation (ICCC) | $4.80 | - | - | 13.3M | Strong Buy |
| Prothena Corporation PLC (PRTA) | $17.36 | - | - | 601.1M | Strong Buy |
| ProPhase Labs Inc (PRPH) | $1.55 | - | - | 28.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
